| Primary |
| Product Used For Unknown Indication |
27.3% |
| Type Ii Diabetes Mellitus |
27.3% |
| Constipation |
18.2% |
| Diabetes Mellitus |
18.2% |
| Colonoscopy |
9.1% |
|
| Sudden Cardiac Death |
50.0% |
| Vomiting |
50.0% |
|
| Secondary |
| Constipation |
16.3% |
| Product Used For Unknown Indication |
12.8% |
| Drug Use For Unknown Indication |
11.2% |
| Prophylaxis |
8.9% |
| Schizophrenia |
8.4% |
| Infection Prophylaxis |
7.0% |
| Hyperphosphataemia |
4.9% |
| Eczema |
3.7% |
| Infection |
3.0% |
| Pyrexia |
3.0% |
| Parkinson's Disease |
2.8% |
| Asthma |
2.3% |
| Compression Fracture |
2.3% |
| Peripheral Sensory Neuropathy |
2.1% |
| Allergy Prophylaxis |
1.9% |
| Dementia Alzheimer's Type |
1.9% |
| Dry Skin Prophylaxis |
1.9% |
| Eczema Asteatotic |
1.9% |
| Hypokalaemia |
1.9% |
| Type 2 Diabetes Mellitus |
1.9% |
|
| Urinary Retention |
29.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
16.4% |
| Pancreatitis |
7.5% |
| Vomiting |
6.0% |
| Ileus |
4.5% |
| Shock |
4.5% |
| Sudden Cardiac Death |
4.5% |
| Deafness Neurosensory |
3.0% |
| Hepatic Function Abnormal |
3.0% |
| Large Intestinal Ulcer Haemorrhage |
3.0% |
| Pyelonephritis |
3.0% |
| Renal Failure Acute |
3.0% |
| Abdominal Distension |
1.5% |
| Drug Ineffective |
1.5% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
1.5% |
| Haematuria |
1.5% |
| Hypotonia |
1.5% |
| Infectious Peritonitis |
1.5% |
| Intestinal Ischaemia |
1.5% |
| Intestinal Perforation |
1.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
46.7% |
| Constipation |
9.5% |
| Prophylaxis |
7.9% |
| Drug Use For Unknown Indication |
6.7% |
| Infection Prophylaxis |
4.3% |
| Hypertension |
3.3% |
| Schizophrenia |
2.8% |
| Aplastic Anaemia |
2.3% |
| Pain |
2.1% |
| Premedication |
1.9% |
| Insomnia |
1.6% |
| Non-small Cell Lung Cancer |
1.6% |
| Prophylaxis Of Nausea And Vomiting |
1.3% |
| Diabetes Mellitus |
1.2% |
| Graft Versus Host Disease |
1.2% |
| Cancer Pain |
1.2% |
| Back Pain |
1.1% |
| Prostate Cancer Stage Iv |
1.1% |
| Prophylaxis Against Graft Versus Host Disease |
1.1% |
| Depression |
1.1% |
|
| White Blood Cell Count Decreased |
9.5% |
| Vomiting |
7.8% |
| Ileus |
6.7% |
| Pneumonia |
6.7% |
| Pyrexia |
6.1% |
| Staphylococcal Sepsis |
6.1% |
| Urinary Tract Infection |
6.1% |
| Fungal Infection |
5.0% |
| White Blood Cell Count Increased |
5.0% |
| Pneumonia Aspiration |
4.5% |
| Prostatic Specific Antigen Increased |
4.5% |
| Sudden Death |
4.5% |
| Stomatitis |
3.9% |
| Weight Decreased |
3.9% |
| Psychiatric Symptom |
3.4% |
| Renal Failure Acute |
3.4% |
| Renal Impairment |
3.4% |
| Ventricular Tachycardia |
3.4% |
| Wound Infection |
3.4% |
| Pain In Extremity |
2.8% |
|
